Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride

EU orphan designation number: EU/3/13/1136   
Active ingredient: 5-[1-(2,6-dichlorobenzyl)piperidin-4-ylmethoxy]quinazoline-2,4-diamine dihydrochloride
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: Sirius Regulatory Consulting Limited
29 Hamblin Meadow, Eddington, Hungerford, Berkshire, RG17 0HJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Orphan designation EMA/OD/034/13 (2013)3671 of 7/06/2013
26/09/2013 Transfer of orphan designation EMA/OD/034/13/T/01 (2013)6305 of 24/09/2013
28/09/2016 Transfer of orphan designation EMA/OD/034/13/T/02 (2016) 6301 of 26/09/2016